Check out our most popular compounded medications! Get Started
Ephedrine Sulfate 50 mg Slow Release Capsules are crafted with Methocel E4M, a controlled-release polymer. This formulation ensures a gradual release of the active ingredient, offering sustained therapeutic effects for conditions such as asthma, bronchitis, chronic obstructive pulmonary disease, allergic rhinitis, and hypertension. The slow release mechanism enhances patient compliance by reducing dosing frequency, making it ideal for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ephedrine Sulfate 50 mg Slow Release Capsules are a meticulously crafted prescription medication, designed to treat a variety of conditions including asthma, bronchitis, chronic obstructive pulmonary disease, allergic rhinitis, and hypertension. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which guarantees a gradual and sustained release of the active ingredient, ephedrine sulfate. The slow-release mechanism ensures a steady therapeutic effect, reducing the need for frequent dosing and thereby enhancing patient compliance.
The active ingredient in these capsules, ephedrine sulfate, is a sympathomimetic amine. It works by stimulating the sympathetic nervous system, which can help to alleviate airway obstruction and improve breathing in patients suffering from respiratory conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease. Additionally, ephedrine sulfate can help to reduce inflammation and swelling in the nasal passages. For patients with hypertension, ephedrine sulfate can aid in reducing blood pressure.
The slow and sustained release of ephedrine sulfate in this formulation helps to minimize the risk of side effects associated with higher doses of the medication. This makes Ephedrine Sulfate 50 mg Slow Release Capsules a appropriate treatment option for managing a variety of conditions. The incorporation of Methocel E4M in the formulation ensures a controlled and prolonged release profile, offering sustained therapeutic effects and improved patient compliance.
Furthermore, the use of Methocel E4M in this formulation not only ensures a controlled and prolonged release profile but also contributes to the overall stability of the formulation. This polymer is known for its excellent compatibility with a wide range of active pharmaceutical ingredients and its ability to maintain the integrity of the formulation even under varying physiological conditions. This ensures that the therapeutic efficacy of the medication is maintained throughout the duration of the treatment.
If you have any questions about this formulation or how it can help to treat your condition, please do not hesitate to reach out to us. We are committed to providing comprehensive information and support to ensure the best possible patient outcomes. Our team of experienced pharmacists and healthcare professionals are always ready to assist you with any queries or concerns you may have regarding this medication.
Ephedrine Sulfate 50 mg Slow Release Capsules are a specially compounded formulation intended for the management of various respiratory and cardiovascular conditions. These include Asthma, Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, and Hypertension. The active ingredient, Ephedrine Sulfate, is a sympathomimetic amine that serves as a bronchodilator, vasoconstrictor, and nasal decongestant.
The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer. This innovative design ensures the gradual release of the encapsulated Ephedrine Sulfate over an extended period. The slow-release mechanism provides sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, especially for medications that necessitate a controlled and prolonged release profile.
Ephedrine Sulfate functions by stimulating the alpha and beta-adrenergic receptors, which can help to alleviate airway obstruction and enhance breathing in patients with Asthma and Bronchitis. It also assists in reducing inflammation and mucus production in the airways, thereby improving symptoms of COPD. For patients with Allergic Rhinitis, Ephedrine Sulfate can help to relieve nasal congestion and other related symptoms. Additionally, it can help to lower blood pressure in patients with Hypertension.
When using Ephedrine Sulfate 50 mg Slow Release Capsules, it is essential to follow the instructions provided by your healthcare provider. The medication should be taken as prescribed, and it is crucial not to exceed the recommended dose. Patients should also avoid taking other medications that may interact with Ephedrine Sulfate, such as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and certain antihistamines. If you have any concerns about potential interactions between Ephedrine Sulfate and other medications, it is advised to consult with your healthcare provider.
Ephedrine Sulfate 50 mg Slow Release Capsules are a specially compounded formulation designed to treat a variety of conditions including asthma, bronchitis, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and hypertension. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated ephedrine sulfate over an extended period. This slow release formulation provides a sustained therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance.
The active ingredient in these capsules, ephedrine sulfate, works by stimulating the release of adrenaline. This action helps to relax the airways and reduce inflammation, thereby alleviating symptoms of asthma, bronchitis, and COPD. It also helps to mitigate the severity of allergic rhinitis. Furthermore, ephedrine sulfate can help to lower blood pressure.
When using Ephedrine Sulfate 50 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider. The typical recommended dose is one capsule taken twice daily, with or without food. To ensure a consistent therapeutic effect, it is important to take the capsules at the same time each day. Avoid exceeding the recommended dose to prevent the risk of potential side effects.
Certain individuals, such as those with heart disease, high blood pressure, thyroid disease, diabetes, or prostate enlargement, may need to avoid this medication or use it under close medical supervision. Always consult with your healthcare provider before starting any new medication.
If you have any queries or concerns about Ephedrine Sulfate 50 mg Slow Release Capsules, please do not hesitate to reach out. We are committed to helping you understand your medication and achieve the best possible health outcomes.
Ephedrine Sulfate 50 mg Slow Release Capsules are a meticulously compounded formulation, specifically designed to provide a controlled and prolonged release of the active ingredient, Ephedrine Sulfate. The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer allows for the gradual release of the medication over an extended period, ensuring sustained therapeutic effects.
The use of Methocel E4M in the formulation not only ensures a steady release of the medication but also reduces the frequency of dosing. This feature significantly improves patient compliance, making it an ideal choice for medications that require a controlled release profile. The slow release of the medication ensures a steady state of the drug in the body, providing consistent therapeutic effects.
Ephedrine Sulfate 50 mg Slow Release Capsules have been used off-label for the management of various conditions. These include narcolepsy, obesity, and hypotension. The capsules have also been used to alleviate symptoms of colds and flu, such as nasal congestion, coughing, and sneezing. Additionally, they have been employed to manage symptoms of altitude sickness, including headache, dizziness, and fatigue.
Despite its benefits, Ephedrine Sulfate should not be used in patients with a history of cardiovascular disease, hypertension, or glaucoma. Potential side effects of Ephedrine Sulfate include restlessness, insomnia, and anxiety. It is strongly recommended that patients consult with their healthcare provider if they have any questions or concerns about the use of Ephedrine Sulfate 50 mg Slow Release Capsules. This ensures that the medication is used safely and effectively, providing the maximum therapeutic benefit while minimizing potential risks.
Ephedrine Sulfate 50 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to gradually release the encapsulated medication over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
The benefits of using this medication include sustained therapeutic effects due to the gradual release of the active ingredient, reduced dosing frequency, and improved patient compliance due to the controlled and prolonged release profile.
The slow release mechanism works by gradually releasing the encapsulated medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which is designed to control the release of the active ingredient.
Methocel E4M is a type of controlled-release polymer that is used in the formulation of certain medications. It is designed to control the release of the active ingredient over an extended period of time.
The dosing frequency of Ephedrine Sulfate 50 mg Slow Release Capsules is reduced due to the controlled and prolonged release profile of the medication. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
As with any medication, Ephedrine Sulfate 50 mg Slow Release Capsules may cause side effects. It's important to discuss potential side effects with your healthcare provider before starting this medication.
Ephedrine Sulfate 50 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It may not be suitable for everyone, and your healthcare provider will determine if this medication is right for you based on your specific medical condition and response to therapy.
It's important to continue taking Ephedrine Sulfate 50 mg Slow Release Capsules as directed by your healthcare provider, even if you feel better. Stopping the medication abruptly may cause adverse effects or a relapse of your condition.
If you miss a dose of Ephedrine Sulfate 50 mg Slow Release Capsules, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
